However, the Congress instead passed a short-term spending bill on January 18 to keep the funded until the beginning of March, buying lawmakers more time to finish the formal appropriations process. This stop-gap legislation does not include various healthcare extender measures, including our provision to continue the 75/25 blended rate for Medicare reimbursement in non-rural areas.
We need to continue to push to help get this relief included in the next government funding legislation that is needed to pass before the new March 1 deadline. Please send a letter to your Senators and House member encouraging them to reach out to leadership in their respective chambers in support of including DME relief measures (S. 1294 and H.R. 5555 provisions) in the next upcoming government funding bill. There is considerable competition from the full scope of corporate groups and other interests to have their priorities addressed in this legislative vehicle -- including the healthcare advocacy groups -- so your help keeping our bills at the top-of-mind for Congressional leadership is critical.
You are encouraged to edit the draft letter at right to include more details about your company and patients, as well as how the disconnect between current reimbursement rates and rising product and operational costs that have now taken effect are affecting your business and your patients.
Please also share this link with your co-workers, friends, and peers -- and ask them to send a message, as well. Thank you for your advocacy!